Impact of the AT(2) Receptor Agonist C21 on Blood Pressure and Beyond

Sebastien Foulquier, U. Muscha Steckelings, Thomas Unger*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)
Original languageEnglish
Pages (from-to)403-409
JournalCurrent Hypertension Reports
Issue number5
Publication statusPublished - Oct 2012


  • Hypertension
  • Blood pressure
  • Angiotensin
  • AT(2)R
  • Renin-angiotensin system
  • RAS
  • Compound 21
  • C21
  • Inflammation
  • Antihypertensive drug therapy

Cite this